Anebulo Pharmaceuticals, Inc. — Form D
Anebulo Pharmaceuticals, Inc. of LAKEWAY, TX, a company, filed a Form D exempt-offering notice with the SEC on 2022-10-11. The offering totals $16.2M, of which $6.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-10-11
- Form: D
- Accession: 0001169987-22-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $16.2M
- Amount sold: $6.6M
- Remaining: $9.5M
- Investors: 5
- Date of first sale: 2022-09-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-461214
Issuer
- Name: Anebulo Pharmaceuticals, Inc.
- CIK: 0001815974
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1017 RANCH ROAD 620 SOUTH, LAKEWAY, TX, 78734
- Phone: (512) 598-0931
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Simon Allen | Director | Lakeway, TX |
| Karah R Parschauer | Director | Lakeway, TX |
| Simon Allen | Executive Officer | Lakeway, TX |
| Kenneth C Cundy | Executive Officer | Lakeway, TX |
| James R Merchant | Executive Officer | Salt Lake City, UT |
| Richard Cunningham | Director | Lakeway, TX |
| Richard Cunningham | Executive Officer | Lakeway, TX |
| Daniel George | Executive Officer | Lakeway, TX |
| Jason R Aryeh | Director | Lakeway, TX |
| Aron R English | Director | Lakeway, TX |
| Kenneth R Lin | Director | Lakeway, TX |
| Joseph F Lawler | Director | Lakeway, TX |
| Joseph F Lawler | Executive Officer | Lakeway, TX |
| Areta R Kupchyk | Director | Lakeway, TX |
| Bimal R Shah | Director | Lakeway, TX |
| Nathaniel R Calloway | Director | Lakeway, TX |
| Aron F English | Director | Lakeway, TX |
Other filings by this issuer (2)
More